Weighing less than 20 pounds, the MyLab30 CV ultrasound system is the first compact ultrasound system to deliver premium ...
The Infinix VF-i/SP X-ray system is a universal cardiovascular system designed to accommodate diagnostic and ...
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Cordis Corp. recently introduced the REGATTA Steerable Guidewire family of devices in the U.S., which 12 selections of ...
May 9 — Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures LLC have announced the creation of a ...
z.one, the first convertible ultrasound system, provides the flexibility to instantly convert from a full-featured, cart ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider range of ...
MedicalCV Inc. has received FDA clearance for its SOLAR Surgical Ablation System for the ablation of soft tissue. The ...
The TURBO elite product line for excimer laser ablation is comercially available to treat peripheral artery disease (PAD). The line features an enhanced outer jacket and inner guide wire lumen with optimized ablation efficiency and energy output that enables increased penetration rates.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 9, 2007 — Biosense Webster Inc., a worldwide leader in cardiac mapping and ablation, and Medtronic Inc., world leader in implanted cardiac rhythm devices, have announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.
In the world of cardiologists who treat adults with congenital heart disease, the unusual is not so very unusual and the rare is fairly commonplace. Take Wendy Book, M.D., for example — this week she might meet for the first time a patient presenting with a heart defect from birth for which there is no standard therapy, and for whom there may well be no exact replica on record.
In 2006, the baby boom generation (those born from 1946 - 1964) started turning 60 at the rate of 330 per hour ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
In a giant leap forward in ICD patient safety, the American College of Cardiology Foundation (ACCF), in conjunction with the Heart Rhythm Society (HRS), established the National Cardiovascular Data Registry's national ICD Registry in the fall of 2005 to measure ICD patient outcomes and track patient trends.
Sometimes it's the smallest things that leave the strongest impression. Of the dozens of technologies with which I came ...
When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.
May 08, 2007
